ArticleHaematologica2010

In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.

Enrique M Ocio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.